Ginkgo ketone ester tablets for the treatment of cognitive impairment associated with chemotherapy for breast cancer - a prospective cohort study.

8.38 ± 1.50 (P < 0.001) Secondary outcomes Quality of life assessment (FACT-Cog) The exposed group showed improvement trends across all FACT-Cog domains compared to controls, though differences did not reach statistical significance (P > 0.05 for all domains). • Perceived cognitive impairment scores showed favorable trends • Perceived cognitive abilities demonstrated modest improvements • Impact on quality of life measures indicated positive direction • Others’ evaluations reflected beneficial tendencies.

also in 111,027 other papers